An in vivo Biomarker to Characterize Ototoxic Compounds and Novel Protective Therapeutics

Overview of attention for article published in Frontiers in Molecular Neuroscience, July 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 75,912 followers.

New article: An in vivo Biomarker to Characterize Ototoxic Compounds and Novel Protective Therapeutics https://t.co/Fk7jMqOxxd #kidneycancer #oncology https://t.co/hsQrgc5HYJ

04 Aug 2022

Reply Repost Favourite

New Research: An in vivo Biomarker to Characterize Ototoxic Compounds and Novel Protective Therapeutics: There are no approved therapeutics for the prevention of hearing loss and vestibular dysfunction from drugs like… https://t.co/sYo1QEcBuA #Molecular #N

29 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.